Bifogade filer
Cellavision Q2 - Mostly in line with some minor issues
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
2024-07-19 16:36:00
Redeye’s view on the Q2 report. The organic growth was decent, while the gross margin development comprised most of the deviation compared to the results. We have decreased our sales estimates slightly due to uncertainty in the Americas and decreased our gross margin assumptions for the rest of 2024 and for the following years. With these changes and balance sheet adjustments, we have slightly increased our Base case to SEK 250 (245) and fair value range of SEK 165 – 388 per share
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/